3rd Canadian firm wins OK to grow, sell MMJ in Colombia

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.

Another company with strong Canadian ties said it received a license this week to begin the cultivation, distribution and export of medical marijuana in Colombia.

CannaVida SAS – based in Colombia and run by a team of Canadian executives – said it will proceed with the production of its 2-million-square-foot (185,000-square-meter) cultivation facility in Santander, Colombia.

The company also said it received a permit to commence construction of a 450,000-square-foot “cannabis campus,” which will include a 15,000-square-foot processing and extraction laboratory.

Two other Canadian companies said they received medical marijuana licenses in Colombia this week:

  • Toronto-based Khiron Life Sciences said its subsidiary, Khiron Colombia SAS, has been granted all the licenses required for the cultivation, domestic distribution and export of medical cannabis in Colombia.
  • Toronto-based PharmaCielo’s subsidiary in Colombia, PharmaCielo Colombia Holdings S.A.S., has also received licenses for the cultivation, domestic distribution and export of medical cannabis.

Colombia legalized medical marijuana two years ago.

To sign up for our weekly Canada marijuana business newsletter, click here.